Stay updated on ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Sign up to get notified when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.

Latest updates to the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page
- Check7 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site footer now displays software revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check34 days agoChange DetectedThe history shows the contact information label was updated in capitalization, and a new site version v3.7.0 was added while the older label and version (Find Contact Information, v3.6.6) were removed; together these illustrate a minor UI text adjustment and a software release entry on the page.SummaryDifference0.2%

- Check56 days agoChange DetectedA new revision entry v3.6.6 was added to the study's Record History, and the previous revision v3.6.5 was removed. This reflects an updated version of the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry, v3.6.5, was added to the record history and the prior revision, v3.6.4, was removed from the visible history.SummaryDifference0.1%

- Check91 days agoChange DetectedA new revision entry v3.6.4 was added to the record history and the previous v3.6.3 entry was removed, indicating an update to the page's release notes.SummaryDifference0.1%

Stay in the know with updates to ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.